Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia
Author:
Publisher
Springer New York
Link
http://link.springer.com/content/pdf/10.1007/978-1-4939-7299-9_6
Reference106 articles.
1. Rees DC, Williams TN, Gladwin MT: Sickle-cell disease. Lancet, 376:2018-2031.
2. Cappellini MD, Bejaoui M, Agaoglu L, Canatan D, Capra M, Cohen A, Drelichman G, Economou M, Fattoum S, Kattamis A, et al: Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. Blood 2011, 118:884-893.
3. Gardenghi S, Grady RW, Rivella S: Anemia, Ineffective Erythropoiesis, and Hepcidin: Interacting Factors in Abnormal Iron Metabolism Leading to Iron Overload in beta-Thalassemia. Hematol Oncol Clin North Am 2010, 24:1089-1107.
4. Musallam KM, Cappellini MD, Wood JC, Taher AT: Iron overload in non-transfusion-dependent thalassemia: a clinical perspective. Blood Rev 2012, 26 Suppl 1:S16-19.
5. Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, et al: Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study. Ann Hematol 2013, 92:1485-1493.
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Drug product attributes predict clinical efficacy in betibeglogene autotemcel gene therapy for β-thalassemia;Molecular Therapy - Methods & Clinical Development;2023-12
2. Genetics Matters: Voyaging from the Past into the Future of Humanity and Sustainability;International Journal of Molecular Sciences;2022-04-02
3. Gene therapy in the fight against pediatric blood disorders: sickle cell disease and beta-thalassemia;Drugs of the Future;2022
4. HSCT remains the only cure for patients with transfusion-dependent thalassemia until gene therapy strategies are proven to be safe;Bone Marrow Transplantation;2021-09-16
5. Genome-based therapeutic interventions for β-type hemoglobinopathies;Human Genomics;2021-06-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3